New Funding Awards April 2022

Friday, May 20, 2022

Sponsored Research

Andrew Alspaugh of Infectious Diseases has received an award from the National Institutes of Health for a project entitled "Arrestin proteins mediate microbial cellular adaptation and fungal virulence - R21." Total funding will be $442,750.

Daniel Friedman of Cardiology has received a sub-award through the Yale University for a project entitled "Safety and Effectiveness of Left Atrial Appendage Closure in Atrial Fibrillation (SAFELY-AF)." Total funding will be $54,450.

Stephen Greene of Cardiology has received an award from the American Heart Association for a project entitled "Use and Effectiveness of Outpatient Intravenous Diuretic Therapy as Treatment for Worsening Heart Failure." Total funding will be $230,923.

Shiaowen Hsu of Oncology has received an award from the Mario Family Foundation for a project entitled "Precision Medicine Trial Using MicroOrganoSpheres to Guide Care in Colorectal Cancer." Total funding will be $304,000.

Yubin Kang of Cell Therapy has received an award from the American Society of Hematology for a project entitled "THIOREDOXIN REGULATES P53 TRANSCRIPTION IN HEMATOPOIETIC STEM CELLS." Total funding will be $42,000.

Thuy Le of Infectious Diseases has received an award from the National Institutes of Health for a project entitled "Tropical Medicine Research Center for Talaromycosis in Vietnam - U01." Total funding will be $2,509,891.

Deborah Muoio of Endocrinology has received an award from the National Institutes of Health for a project entitled "Novel roles of PDK4 in regulating mitochondrial protein phosphorylation, carbon flux and metabolic resilience." Total funding will be $3,216,207.

Deborah Muoio of Endocrinology has received an award from the National Institutes of Health for a project entitled "Novel roles of PDK4 in regulating mitochondrial protein phosphorylation, carbon flux and metabolic resilience." Total funding will be $3,216,207.

David Murdoch of Pulmonary has received an award from the Institute for Medical Research, Inc. for a project entitled "IMR PSA: Alicia Volkheimer." Total funding will be $27,518.

Andrew Nixon of Oncology has received an award from the Mario Family Foundation for a project entitled "Single-cell cytokine profiling in metastatic colorectal cancer patients receiving immunotherapy." Total funding will be $52,000.

Charity Oyedeji of Hematology has received a sub-award through the Augusta University for a project entitled "PRIDE-Functional and Translational Genomics of Blood Disorders." Total funding will be $11,880.

Manesh Patel of Cardiology has received a sub-award through the OCHIN for a project entitled "AIM-AHEAD Coordinating Center Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Researcher Diversity: Data/Research Core." Total funding will be $322,702.

Jennifer Rymer of Cardiology has received an award from the American Heart Association for a project entitled "Implementation of a Medication Adherence Instrument Among Patients with Symptomatic Peripheral Artery Disease after PVI." Total funding will be $229,347.

James Wharam of General Internal Medicine has received an award from the Centers for Disease Control and Prevention for a project entitled "Long-term Impact of Reduced Patient Out-of-pocket Costs on Diabetes Complications (NEXT-D 3)." Total funding will be $537,732.

Christina Wyatt of Nephrology has received a sub-award through the Vanderbilt University Medical Center for a project entitled "Etiology of Persistent Microalbuminuria in Nigeria (R01)." Total funding will be $16,060.

 

Industry Sponsored Clinical Trials

Andrew Armstrong of Oncology has received an award from Biosplice Therapeutics, Inc for a project entitled "A Phase 1b, Open-Label, Dose-Escalation, Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Orally Administered SM08502 Combined with Hormonal Therapy or Chemotherapy in Subjects with Advanced Solid Tumors." Total funding will be $1,116,422.

Cristiana Costa Chase of Cell Therapy has received an award from Kangpu Biopharmaceuticals, Ltd. for a project entitled "A Phase 1, Multicenter, Open-label, Multiple-ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of KPG-818 in Subjects with Hematological Malignancies." Total funding will be $803,272.

Anna Mae Diehl of Gastroenterology has received an award from Madrigal Pharmaceuticals, Inc. for a project entitled "Madrigal 3196-18 A 52-Week, Phase 3 Open-Label Extension Study, with a Resmetirom (MGL-3196) in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension." Total funding will be $94,077.

Carlos Decastro of Cell Therapy has received an award from Novartis Pharmaceuticals Corporation for a project entitled "Novartis: Single-Arm, Open-Label, Ph2 of MBG453 added to Hypomethylating Agent for MDS." Total funding will be $348,175.

Cristina Gasparetto of Cell Therapy has received an award from AbbVie Inc. for a project entitled "FULL TITLE: A Phase 1b, Dose Escalation and Expansion Study of Lemzoparlimab (TJ011133) with or without Dexamethasone and in Combination with Anti-Myeloma Regimens for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma." Total funding will be $2,252,773.

Coral Giovacchini of Pulmonary has received an award from Nucleix, Inc. for a project entitled "Determination and Validation of Lung EpiCheck�: A Multianalyte Assay for Lung Cancer Prediction." Total funding will be $403,683.

Christopher Hoimes of Oncology has received an award from Aravive, Inc for a project entitled "Aravive 003: AVB-S6-500 A phase 1b/2 study of AVB-S6-500 in combination with cabozantinib, AVB-S6-500 in combination with cabozantinib and nivolumab, and AVB-S6-500 monotherapy in patients with advanced of metastatic clear cell renal cell carcinoma." Total funding will be $173,942.

Michel Khouri of Cardiology has received an award from Alnylam Pharmaceuticals for a project entitled "ConTTRibute." Total funding will be $251,416.

Michel Khouri of Cardiology has received an award from Eidos Therapeutics for a project entitled "Attribute OLE." Total funding will be $232,497.

Michel Khouri of Cardiology has received an award from Moleculin Biotech, Inc. for a project entitled "ANNAMYCIN III - Acute Myeloid Leukemia." Total funding will be $177,280.

Renato Lopes of Cardiology has received an award from Priovant Therapeutics, Inc for a project entitled "Priovant BREPO." Total funding will be $354,064.

Micah McClain of Infectious Diseases has received an award from Janssen Research & Development, LLC for a project entitled "Acute Respiratory Infections Global Outpatient Study (ARGOS).." Total funding will be $71,303.

Lake Morrison of Pulmonary has received an award from ORINOVE, Inc for a project entitled "AZ ORIN1001-002 D4325C00001: Phase 1b Double-Blind, Placebo-Controlled, Ascending Dose Trial: ORIN1001 in Subjects with Idiopathic Pulmonary Fibrosis." Total funding will be $213,217.

Michael Morse of Oncology has received an award from ITM Solucin GmbH for a project entitled "[DP-1111-02CT] A Prospective, Randomized, Controlled, Open-label, Multicenter Trial to Evaluate Efficacy, Safety and Patient-reported Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) with Lutetium (177Lu) Edotreotide compared to Best Standard." Total funding will be $888,476.

Opeyemi Olabisi of Nephrology has received an award from Lilly USA, LLC for a project entitled "A-018101 Lilly USA." Total funding will be $0.

Richard Riedel of Oncology has received an award from PF Argentum IP Holdings LLC for a project entitled "Trillium TTI-621-03." Total funding will be $409,582.

Jason Somarelli of Oncology has received an award from Dolphin Quest for a project entitled "An integrated physiology and genomics analysis to define molecular adaptations to diving." Total funding will be $8,000.

Deepak Voora of Cardiology has received an award from Abbott Laboratories for a project entitled "Abbott Diagnostics Collaborative Sponsored Research Agreement." Total funding will be $199,471.

Jie Wang of Cell Therapy has received an award from Daiichi Sankyo Inc for a project entitled "Single-Arm, Phase 2 Study of Valemetostat Tosylate Monotherapy in Subjects with Relapsed/Refractory Peripheral T-Cell Lymphoma (Valemetostat tosylate [DS-3201b], an enhancer of zeste homolog [EZH] 1/2 dual inhibitor, for R/R PTCL)." Total funding will be $633,296.

Yu-Ping Wang of Cardiology has received an award from American College of Cardiology for a project entitled "CPMI Amendment #26 Single Man � Industry." Total funding will be $60,000.

Chris Woods of Infectious Diseases has received an award from Abbott Laboratories for a project entitled "Clinical Evaluation of the Investigational ID NOW COVID-19 Assay Scientific Publication." Total funding will be $36,225.